KOMIPHARM INTERNATIONAL CO., LTD.
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
041960 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 시흥시 경제로 17, 시흥시
- Website:
- https://komipharm.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Komipharm International Co., Ltd. is a biopharmaceutical company with core operations in animal health and a strategic focus on human therapeutics. The company develops, manufactures, and sells a diverse portfolio of veterinary products, including vaccines, pharmaceuticals, and disinfectants for livestock, poultry, and companion animals. Leveraging over 50 years of industry experience, Komipharm is also engaged in the research and development of novel drugs for human use. Its pharmaceutical pipeline concentrates on creating therapeutic agents for challenging indications such as cancer pain and autoimmune diseases, as part of its strategy to expand into the global bio-industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-15 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(약식)
|
Korean | 122.0 KB | ||
| 2025-09-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 78.6 KB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.9 MB | ||
| 2025-08-06 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2025-07-30 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 61.3 KB | ||
| 2025-07-07 00:00 |
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 10.8 KB | ||
| 2025-06-20 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 37.4 KB | ||
| 2025-06-20 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
|
Korean | 32.7 KB | ||
| 2025-05-27 00:00 |
Capital/Financing Update
주요사항보고서(제3자의전환사채매수선택권행사)
|
Korean | 23.3 KB | ||
| 2025-05-14 00:00 |
Annual Report
분기보고서 (2025.03)
|
Korean | 1.9 MB | ||
| 2025-04-29 00:00 |
Share Issue/Capital Change
[기재정정]전환청구권행사
|
Korean | 14.4 KB | ||
| 2025-04-23 00:00 |
Share Issue/Capital Change
전환청구권행사
|
Korean | 11.1 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 31.6 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.1 KB | ||
| 2025-03-26 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
|
Korean | 32.7 KB |
Automate Your Workflow. Get a real-time feed of all KOMIPHARM INTERNATIONAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for KOMIPHARM INTERNATIONAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
